Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Promising phase III trial results presented for Coulter's lead cancer therapy

Dec. 29, 1998

Merck obtains option to expand MDX-447 collaboration with Medarex

Dec. 29, 1998

FDA grants fast track designation for OvaRex MAb

Dec. 22, 1998

Cell Genesys and Japan Tobacco enter worldwide collaboration for GVAX cancer vaccine

Dec. 22, 1998

Dendreon presents phase I/II data on APC-8020 at ASH meeting

Dec. 16, 1998

Seattle Genetics initiates a phase I clinical trial of SGN-10

Dec. 16, 1998

AVI BioPharma reports encouraging clinical data from phase II Avicine study

Dec. 15, 1998

MAb-tyrosine kinase inhibitor immunoconjugate induces disease remission in ALL patients

Dec. 14, 1998

Novel GM-CSF-containing fusion toxin shows excellent antileukemia activity in mouse model

Dec. 14, 1998

Lorus Therapeutics announces final phase I/II pancreatic cancer trial data

Dec. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...